Volume 88 Issue 4 | pp. 22-23
Issue Date: January 25, 2010

Against The Grain

Forma Therapeutics bets on market's appetite for its platform technology
Department: Business, Science & Technology | Collection: Economy
Keywords: Forma, Broad Institute, Cubist, Novartis Option Fund

In a financing environment that calls for most new biotech companies’ operations to consist of only a briefcase and a BlackBerry, Forma Therapeutics is an outlier. Just a year old, the firm has taken on more than 85 employees, set up sparkling labs in the Science Hotel facility, in Cambridge, Mass., and put together an integrated drug discovery platform. With technology in chemistry and biology, the company believes it can build a pipeline . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society